2025. Glycemic Outcomes Of Dapagliflozin, Glimepiride, And Sitagliptin As Add-On Therapy To Metformin In Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study. The Review of Diabetic Studies . (Sep. 2025), 693–700. DOI:https://doi.org/10.70082/qs5vrk14.